NTLA
Price
$17.65
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
21 days until earnings call
TECH
Price
$74.26
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
18 days until earnings call
Ad is loading...

NTLA vs TECH

Header iconNTLA vs TECH Comparison
Open Charts NTLA vs TECHBanner chart's image
Intellia Therapeutics
Price$17.65
Change-$0.00 (-0.00%)
Volume$1.51M
CapitalizationN/A
Bio-Techne
Price$74.26
Change-$0.00 (-0.00%)
Volume$459.01K
CapitalizationN/A
View a ticker or compare two or three
NTLA vs TECH Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
NTLA vs. TECH commentary
Oct 11, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a StrongSell and TECH is a StrongSell.

COMPARISON
Comparison
Oct 11, 2024
Stock price -- (NTLA: $17.65 vs. TECH: $74.26)
Brand notoriety: NTLA and TECH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 108% vs. TECH: 52%
Market capitalization -- NTLA: $2.13B vs. TECH: $12.49B
NTLA [@Biotechnology] is valued at $2.13B. TECH’s [@Biotechnology] market capitalization is $12.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 0 FA rating(s) are green whileTECH’s FA Score has 2 green FA rating(s).

  • NTLA’s FA Score: 0 green, 5 red.
  • TECH’s FA Score: 2 green, 3 red.
According to our system of comparison, TECH is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 4 TA indicator(s) are bullish while TECH’s TA Score has 4 bullish TA indicator(s).

  • NTLA’s TA Score: 4 bullish, 3 bearish.
  • TECH’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than TECH.

Price Growth

NTLA (@Biotechnology) experienced а -4.85% price change this week, while TECH (@Biotechnology) price change was -4.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

NTLA is expected to report earnings on Feb 20, 2025.

TECH is expected to report earnings on Feb 04, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($12.5B) has a higher market cap than NTLA($2.13B). TECH YTD gains are higher at: -3.444 vs. NTLA (-42.112). TECH has higher annual earnings (EBITDA): 313M vs. NTLA (-514.18M). NTLA has more cash in the bank: 691M vs. TECH (153M). NTLA has less debt than TECH: NTLA (106M) vs TECH (420M). TECH has higher revenues than NTLA: TECH (1.16B) vs NTLA (46M).
NTLATECHNTLA / TECH
Capitalization2.13B12.5B17%
EBITDA-514.18M313M-164%
Gain YTD-42.112-3.4441,223%
P/E RatioN/A76.13-
Revenue46M1.16B4%
Total Cash691M153M452%
Total Debt106M420M25%
FUNDAMENTALS RATINGS
NTLA vs TECH: Fundamental Ratings
NTLA
TECH
OUTLOOK RATING
1..100
598
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
3
Undervalued
PROFIT vs RISK RATING
1..100
9666
SMR RATING
1..100
9676
PRICE GROWTH RATING
1..100
8537
P/E GROWTH RATING
1..100
10013
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (3) in the Biotechnology industry is somewhat better than the same rating for NTLA (42). This means that TECH’s stock grew somewhat faster than NTLA’s over the last 12 months.

TECH's Profit vs Risk Rating (66) in the Biotechnology industry is in the same range as NTLA (96). This means that TECH’s stock grew similarly to NTLA’s over the last 12 months.

TECH's SMR Rating (76) in the Biotechnology industry is in the same range as NTLA (96). This means that TECH’s stock grew similarly to NTLA’s over the last 12 months.

TECH's Price Growth Rating (37) in the Biotechnology industry is somewhat better than the same rating for NTLA (85). This means that TECH’s stock grew somewhat faster than NTLA’s over the last 12 months.

TECH's P/E Growth Rating (13) in the Biotechnology industry is significantly better than the same rating for NTLA (100). This means that TECH’s stock grew significantly faster than NTLA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTLATECH
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 28 days ago
78%
Bullish Trend 2 days ago
70%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 8 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
63%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
55%
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL229.543.77
+1.67%
Apple
SPY577.143.97
+0.69%
SPDR® S&P 500® ETF Trust
GME20.50-0.21
-1.01%
GameStop Corp
TSLA241.05-3.45
-1.41%
Tesla
BTC.X60582.100000-1549.867200
-2.49%
Bitcoin cryptocurrency

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with EDIT. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-1.34%
EDIT - NTLA
75%
Closely correlated
-1.58%
BEAM - NTLA
75%
Closely correlated
+0.77%
CRSP - NTLA
71%
Closely correlated
+0.42%
VCYT - NTLA
69%
Closely correlated
-4.69%
PRME - NTLA
67%
Closely correlated
-5.82%
More